Skip to content
10-Q

Quarterly Report

4D Molecular Therapeutics, Inc. FDMT

0000950170-25-106244

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 55.93M sh
Shares Diluted Q2 2025 · Jun 30, 2025 55.84M sh
Shares Diluted Q2 2025 · Jun 30, 2024 55.28M sh
Shares Diluted Q2 2025 · Jun 30, 2024 52.28M sh
Capex Q2 2025 · Jun 30, 2025 $697K
Capex Q2 2025 · Jun 30, 2024 $1.06M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$91.14M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$59.33M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $77.16M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $149.34M
Stockholders Equity Q2 2025 · Jun 30, 2025 $420.89M
Stockholders Equity Q2 2025 · Mar 31, 2025 $469.72M
Stockholders Equity Q2 2025 · Dec 31, 2024 $510.61M
Stockholders Equity Q2 2025 · Jun 30, 2024 $588.34M
Stockholders Equity Q2 2025 · Mar 31, 2024 $600.56M
Stockholders Equity Q2 2025 · Dec 31, 2023 $307.83M
Current Liabilities Q2 2025 · Jun 30, 2025 $34.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $29.15M
Total Liabilities Q2 2025 · Jun 30, 2025 $52.75M
Total Liabilities Q2 2025 · Dec 31, 2024 $49.78M
Current Assets Q2 2025 · Jun 30, 2025 $303.29M
Current Assets Q2 2025 · Dec 31, 2024 $434.93M
Total Assets Q2 2025 · Jun 30, 2025 $473.64M
Total Assets Q2 2025 · Dec 31, 2024 $560.38M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.98
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.84
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.63
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.29
Eps Basic Q2 2025 · Jun 30, 2025 −$0.98
Eps Basic Q2 2025 · Jun 30, 2025 −$1.84
Eps Basic Q2 2025 · Jun 30, 2024 −$0.63
Eps Basic Q2 2025 · Jun 30, 2024 −$1.29
Sga Expense Q2 2025 · Jun 30, 2025 $11.52M
Sga Expense Q2 2025 · Jun 30, 2025 $24.46M
Sga Expense Q2 2025 · Jun 30, 2024 $10.6M
Sga Expense Q2 2025 · Jun 30, 2024 $20.9M
Net Income Q2 2025 · Jun 30, 2025 −$54.66M
Net Income Q2 2025 · Jun 30, 2025 −$102.63M
Net Income Q2 2025 · Mar 31, 2025 −$47.97M
Net Income Q2 2025 · Jun 30, 2024 −$34.95M
Net Income Q2 2025 · Jun 30, 2024 −$67.35M
Net Income Q2 2025 · Mar 31, 2024 −$32.4M
Operating Income Q2 2025 · Jun 30, 2025 −$59.46M
Operating Income Q2 2025 · Jun 30, 2025 −$113.08M
Operating Income Q2 2025 · Jun 30, 2024 −$42.46M
Operating Income Q2 2025 · Jun 30, 2024 −$80.59M
Revenue Q2 2025 · Jun 30, 2025 $15K
Revenue Q2 2025 · Jun 30, 2025 $29K
Revenue Q2 2025 · Jun 30, 2024 $5K
Revenue Q2 2025 · Jun 30, 2024 $33K